サマリー

市場の分析と洞察。ペプチド核酸の世界市場
COVID-19の流行により、ペプチド核酸の世界市場規模は2022年に百万米ドルと推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にペプチド核酸世界市場の％を占めたダブルチェーンは、2028年までに百万米ドルの価値を持ち、ポストCOVID-19期間に修正された％のCAGRで成長すると予測されます。一方、Gene Chipセグメントは、この予測期間を通して％CAGRに変更されています。
中国ペプチド核酸の市場規模は2021年に百万米ドル、米国と欧州ペプチド核酸はそれぞれ百万米ドル、百万米ドルと評価されています。米国の割合は2021年に％、中国と欧州はそれぞれ％、％であり、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％であることを追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。ヨーロッパのペプチド核酸の展望としては、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中にCAGR %を推移します。
ペプチド核酸の世界的な主要メーカーは、Abbott Molecular、PerkinElmer、SciGene Corporation、Roche NimbleGen、CytoTestなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。
生産面では、2017年から2022年まで、2028年までの予測で、ペプチド核酸の容量、生産量、成長率、メーカー別、地域別（地域レベル、国レベル）シェアなどを調査しています。
販売面では、ペプチド核酸の地域別（地域レベル、国レベル）、企業別、タイプ別、アプリケーション別の販売に焦点を当て、2017年から2022年まで、2028年までの予測を掲載しています。
世界のペプチド核酸の範囲とセグメント
ペプチド核酸市場は、タイプ別、用途別に分類されます。ペプチド核酸の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析は、2017-2028年の期間において、タイプ別およびアプリケーション別の生産能力、収益、予測に焦点を当てています。
タイプ別セグメント
ダブルチェーン
シングルチェーン
用途別セグメント
遺伝子チップ
電気泳動
蛍光in situハイブリダイゼーション
会社別
アボットモレキュラー
パーキンエルマー
サイジーン株式会社
ロシュ ニンブルジェン
サイトテスト
地域別生産量
北米
欧州
中国
日本
地域別消費量
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Peptide Nucleic Acid Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Nucleic Acid Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Double Chain
1.2.3 Single Chain
1.3 Market by Application
1.3.1 Global Peptide Nucleic Acid Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Study Objectives
1.5 Years Considered
2 Global Peptide Nucleic Acid Production
2.1 Global Peptide Nucleic Acid Production Capacity (2017-2028)
2.2 Global Peptide Nucleic Acid Production by Region: 2017 VS 2021 VS 2028
2.3 Global Peptide Nucleic Acid Production by Region
2.3.1 Global Peptide Nucleic Acid Historic Production by Region (2017-2022)
2.3.2 Global Peptide Nucleic Acid Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Peptide Nucleic Acid Sales in Volume & Value Estimates and Forecasts
3.1 Global Peptide Nucleic Acid Sales Estimates and Forecasts 2017-2028
3.2 Global Peptide Nucleic Acid Revenue Estimates and Forecasts 2017-2028
3.3 Global Peptide Nucleic Acid Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Peptide Nucleic Acid Sales by Region
3.4.1 Global Peptide Nucleic Acid Sales by Region (2017-2022)
3.4.2 Global Sales Peptide Nucleic Acid by Region (2023-2028)
3.5 Global Peptide Nucleic Acid Revenue by Region
3.5.1 Global Peptide Nucleic Acid Revenue by Region (2017-2022)
3.5.2 Global Peptide Nucleic Acid Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Peptide Nucleic Acid Production Capacity by Manufacturers
4.2 Global Peptide Nucleic Acid Sales by Manufacturers
4.2.1 Global Peptide Nucleic Acid Sales by Manufacturers (2017-2022)
4.2.2 Global Peptide Nucleic Acid Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide Nucleic Acid in 2021
4.3 Global Peptide Nucleic Acid Revenue by Manufacturers
4.3.1 Global Peptide Nucleic Acid Revenue by Manufacturers (2017-2022)
4.3.2 Global Peptide Nucleic Acid Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Peptide Nucleic Acid Revenue in 2021
4.4 Global Peptide Nucleic Acid Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Peptide Nucleic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Peptide Nucleic Acid Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Peptide Nucleic Acid Sales by Type
5.1.1 Global Peptide Nucleic Acid Historical Sales by Type (2017-2022)
5.1.2 Global Peptide Nucleic Acid Forecasted Sales by Type (2023-2028)
5.1.3 Global Peptide Nucleic Acid Sales Market Share by Type (2017-2028)
5.2 Global Peptide Nucleic Acid Revenue by Type
5.2.1 Global Peptide Nucleic Acid Historical Revenue by Type (2017-2022)
5.2.2 Global Peptide Nucleic Acid Forecasted Revenue by Type (2023-2028)
5.2.3 Global Peptide Nucleic Acid Revenue Market Share by Type (2017-2028)
5.3 Global Peptide Nucleic Acid Price by Type
5.3.1 Global Peptide Nucleic Acid Price by Type (2017-2022)
5.3.2 Global Peptide Nucleic Acid Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Peptide Nucleic Acid Sales by Application
6.1.1 Global Peptide Nucleic Acid Historical Sales by Application (2017-2022)
6.1.2 Global Peptide Nucleic Acid Forecasted Sales by Application (2023-2028)
6.1.3 Global Peptide Nucleic Acid Sales Market Share by Application (2017-2028)
6.2 Global Peptide Nucleic Acid Revenue by Application
6.2.1 Global Peptide Nucleic Acid Historical Revenue by Application (2017-2022)
6.2.2 Global Peptide Nucleic Acid Forecasted Revenue by Application (2023-2028)
6.2.3 Global Peptide Nucleic Acid Revenue Market Share by Application (2017-2028)
6.3 Global Peptide Nucleic Acid Price by Application
6.3.1 Global Peptide Nucleic Acid Price by Application (2017-2022)
6.3.2 Global Peptide Nucleic Acid Price Forecast by Application (2023-2028)
7 North America
7.1 North America Peptide Nucleic Acid Market Size by Type
7.1.1 North America Peptide Nucleic Acid Sales by Type (2017-2028)
7.1.2 North America Peptide Nucleic Acid Revenue by Type (2017-2028)
7.2 North America Peptide Nucleic Acid Market Size by Application
7.2.1 North America Peptide Nucleic Acid Sales by Application (2017-2028)
7.2.2 North America Peptide Nucleic Acid Revenue by Application (2017-2028)
7.3 North America Peptide Nucleic Acid Sales by Country
7.3.1 North America Peptide Nucleic Acid Sales by Country (2017-2028)
7.3.2 North America Peptide Nucleic Acid Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Peptide Nucleic Acid Market Size by Type
8.1.1 Europe Peptide Nucleic Acid Sales by Type (2017-2028)
8.1.2 Europe Peptide Nucleic Acid Revenue by Type (2017-2028)
8.2 Europe Peptide Nucleic Acid Market Size by Application
8.2.1 Europe Peptide Nucleic Acid Sales by Application (2017-2028)
8.2.2 Europe Peptide Nucleic Acid Revenue by Application (2017-2028)
8.3 Europe Peptide Nucleic Acid Sales by Country
8.3.1 Europe Peptide Nucleic Acid Sales by Country (2017-2028)
8.3.2 Europe Peptide Nucleic Acid Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Peptide Nucleic Acid Market Size by Type
9.1.1 Asia Pacific Peptide Nucleic Acid Sales by Type (2017-2028)
9.1.2 Asia Pacific Peptide Nucleic Acid Revenue by Type (2017-2028)
9.2 Asia Pacific Peptide Nucleic Acid Market Size by Application
9.2.1 Asia Pacific Peptide Nucleic Acid Sales by Application (2017-2028)
9.2.2 Asia Pacific Peptide Nucleic Acid Revenue by Application (2017-2028)
9.3 Asia Pacific Peptide Nucleic Acid Sales by Region
9.3.1 Asia Pacific Peptide Nucleic Acid Sales by Region (2017-2028)
9.3.2 Asia Pacific Peptide Nucleic Acid Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Peptide Nucleic Acid Market Size by Type
10.1.1 Latin America Peptide Nucleic Acid Sales by Type (2017-2028)
10.1.2 Latin America Peptide Nucleic Acid Revenue by Type (2017-2028)
10.2 Latin America Peptide Nucleic Acid Market Size by Application
10.2.1 Latin America Peptide Nucleic Acid Sales by Application (2017-2028)
10.2.2 Latin America Peptide Nucleic Acid Revenue by Application (2017-2028)
10.3 Latin America Peptide Nucleic Acid Sales by Country
10.3.1 Latin America Peptide Nucleic Acid Sales by Country (2017-2028)
10.3.2 Latin America Peptide Nucleic Acid Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Peptide Nucleic Acid Market Size by Type
11.1.1 Middle East and Africa Peptide Nucleic Acid Sales by Type (2017-2028)
11.1.2 Middle East and Africa Peptide Nucleic Acid Revenue by Type (2017-2028)
11.2 Middle East and Africa Peptide Nucleic Acid Market Size by Application
11.2.1 Middle East and Africa Peptide Nucleic Acid Sales by Application (2017-2028)
11.2.2 Middle East and Africa Peptide Nucleic Acid Revenue by Application (2017-2028)
11.3 Middle East and Africa Peptide Nucleic Acid Sales by Country
11.3.1 Middle East and Africa Peptide Nucleic Acid Sales by Country (2017-2028)
11.3.2 Middle East and Africa Peptide Nucleic Acid Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Abbott Molecular
12.1.1 Abbott Molecular Corporation Information
12.1.2 Abbott Molecular Overview
12.1.3 Abbott Molecular Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Abbott Molecular Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Abbott Molecular Recent Developments
12.2 PerkinElmer
12.2.1 PerkinElmer Corporation Information
12.2.2 PerkinElmer Overview
12.2.3 PerkinElmer Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 PerkinElmer Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 PerkinElmer Recent Developments
12.3 SciGene Corporation
12.3.1 SciGene Corporation Corporation Information
12.3.2 SciGene Corporation Overview
12.3.3 SciGene Corporation Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 SciGene Corporation Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 SciGene Corporation Recent Developments
12.4 Roche NimbleGen
12.4.1 Roche NimbleGen Corporation Information
12.4.2 Roche NimbleGen Overview
12.4.3 Roche NimbleGen Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Roche NimbleGen Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Roche NimbleGen Recent Developments
12.5 CytoTest
12.5.1 CytoTest Corporation Information
12.5.2 CytoTest Overview
12.5.3 CytoTest Peptide Nucleic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 CytoTest Peptide Nucleic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 CytoTest Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Peptide Nucleic Acid Industry Chain Analysis
13.2 Peptide Nucleic Acid Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Peptide Nucleic Acid Production Mode & Process
13.4 Peptide Nucleic Acid Sales and Marketing
13.4.1 Peptide Nucleic Acid Sales Channels
13.4.2 Peptide Nucleic Acid Distributors
13.5 Peptide Nucleic Acid Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Peptide Nucleic Acid Industry Trends
14.2 Peptide Nucleic Acid Market Drivers
14.3 Peptide Nucleic Acid Market Challenges
14.4 Peptide Nucleic Acid Market Restraints
15 Key Finding in The Global Peptide Nucleic Acid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer